modernretina6 من الأيام
‎Combination microdrops for ROP screening: Fewer systemic adverse events than standard mydriatrics‎
The rationale was that commercial mydriatics administered during retinopathy of prematurity (ROP) screening have been ...
modernretina14 من الأيام
‎Eyecare wrapped: Top stories from Modern Retina in 2024‎
In 2024, Modern Retina covered news from around the globe on clinical trials, technology in retina, trending topics in ...
modernretina6 من الأيام
‎Ocugen will continue second phase of OCU410 ArMaDa clinical trial‎
The ArMaDa clinical trial is currently being performed at 13 leading retinal surgery centers across the U.S. Dosing in the OCU410 ArMaDa clinical trial will be completed in early 2025 and the Company ...